Second, some mutation targets in DLBCL, such as CHD2, MYD88, PIM1, CD79B, and GNA13 were less frequently mutated in the HBsAg-positive group (Figure 5). The gene discussed is GNA13; the disease is diffuse large B-cell lymphoma.